semaglutide igf1 (generic GLP-1) Bioglutide vs Semaglutide: Next-Gen Oral

2026 is the year in which the long-term themes, the true drivers of sustainable success for the burgeoning landscape of obesity treatment, prescription medicines and beyond, become apparent

Genetics, biology, lifestyle and disease stage all influence their effectiveness

Pharmaceutical giantEli Lilly announced plans Tuesday to invest []

Lipedema, a chronic fat condition that mostly affects women, is characterized by an abnormal accumulation of fat in the hips, thighs, and arms.

This milestone reflects a closely integrated development-to-submission model, with Orbicular leading product development and OneSource supporting the program as the CDMO partner for manufacturing and supply readiness

This Comment highlights emerging evidence and advocates for clinical strategies that prioritize muscle preservation to ensure the long-term success and safety of pharmacological weight management.